Impact Factor
2.27
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.54
194 total citations
h5-index
17
h5 depth signal
Cited share
23.1%
89 of 385
Total citations
194
Citation footprint
Metric signal
1.67
External metric anchor
Self-citation
11.3%
22 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
353
China
116
Italy
61
United Kingdom
60
Turkey
53
Citing Fields of Research
Antibiotic & Antibacterial Agents
374
Pharmacology & Toxicology
351
Veterinary Medicine
317
Anesthetic & Pain Medicine
160
Dairy & Animal Science
103
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,121
Articles tracked across the journal lifetime
Indexed publication set
385
89 cited publications
Last 12 months
88
7.3 publications/month
Open access share
54.5%
48 OA publications in the last year
Leading citing country
United States
353 citing publications
Leading citing field
Antibiotic & Antibacterial Agents
374 citing publications
Latest tracked publication
9 October 2026
10 recent records available
Coverage & Indexing History
v4n1, 1981-
v4n1, 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Pharmacology & Toxicology
Anesthetic & Pain Medicine
Veterinary Medicine
Issuing & Sponsoring Bodies
Contributor
American College of Veterinary Pharmacology & Therapeutics
Contributor
Association for Veterinary Clinical Pharmacology and Therapeutics
Contributor
European Association for Veterinary Pharmacology and Toxicology
Broad Categories
Pharmacology
Therapeutics
Veterinary Medicine
Antibiotic & Antibacterial Agents
Sexually Transmitted Diseases
Molecular & Cellular Toxicology
Agrochemicals & Ground Poisoning
Parasitology
Anesthetic & Pain Medicine
MeSH Descriptors
Drug Therapy
Pharmacology
Veterinary Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/jvp.70116
Open DOI
Preclinical Target Animal Safety Evaluation of Veterinary Monoclonal Antibodies: Principles, Methods, and Interpretation
Monoclonal antibodies (mAbs) represent a rapidly expanding pharmaceutical class in veterinary medicine, with several products now authorized for use in dogs and cats. Limited published articles and veterinarian exposure to the principles...
02
DOI 10.1111/jvp.70115
Open DOI
Tissue Depletion in Dairy Cattle Following Administration of Label or Extralabel Doses of Penicillin G Using Two Different Formulations
Penicillin G has been one of the main violative residues detected at slaughter for 25+ years. Accordingly, a residue depletion study was initiated to determine possible reasons, using a two‐phase approach. Phase 1 involved a 2 × 2 matrix...
03
04
DOI 10.1111/jvp.70114
Open DOI
Pharmacokinetics of Buccally Administered Cannabidiol and Oral Carprofen During Single‐ and Repeated‐Dose Administration in Dogs
Cannabidiol (CBD) is increasingly used as an adjunct treatment for chronic pain in dogs, but information on repeated‐dose pharmacokinetics and potential interactions with commonly used analgesics remains limited. This study evaluated the...
05
DOI 10.1111/jvp.70113
Open DOI
Deciphering Transporter‐Mediated Drug Interactions Affecting Marbofloxacin Residues in Sheep Milk: From In Silico Predictions to In Vivo Validation
Veterinary drug residues in milk represent an important food safety concern, particularly under conditions of co‐administration where transporter‐mediated drug–drug interactions may alter residue profiles. Marbofloxacin, a fluoroquinolon...
06
DOI 10.1111/jvp.70111
Open DOI
Ursodeoxycholic Acid Oral Pharmacokinetics and Plasma Bile Acid Profile Changes in a Population of Healthy Neonatal Foals
Ursodeoxycholic acid (UDCA) is a secondary bile acid used in humans for the treatment of some cholestatic diseases. Interest in its potential use in equine patients with liver conditions has increased. Pharmacokinetic parameters in adult...
07
DOI 10.1111/jvp.70110
Open DOI
Preliminary Comparison of Competitive Efflux and Historical Transwell Assays for Assessing Canine P‐Glycoprotein Substrate Status of Eleven Drugs Representing Ten Different Drug Classes
Because P‐glycoprotein (P‐gp) influences the disposition of substrate drugs, regulatory agencies recommend ascertaining the P‐gp substrate status of active pharmaceutical ingredients (API's) intended for humans. Transwell‐based assays us...
08
09
DOI 10.1111/jvp.70108
Open DOI
A Population Pharmacokinetic Model of Gentamicin in Hospitalized Neonatal Foals
Information on safe and effective gentamicin dosing in foals is limited. This study aimed to provide guidance regarding optimal dosing regimens by means of a population pharmacokinetic (popPK) model. Gentamicin plasma concentration of 29...
10
DOI 10.1111/jvp.70107
Open DOI
Quantitative Pharmacodynamic Analysis of Trimethoprim‐Sulfonamide Combination Activity Against Staphylococcus pseudintermedius
Trimethoprim (TMP)‐sulfonamide combinations are widely used in veterinary medicine, yet the quantitative nature of their pharmacodynamic interaction remains incompletely characterised. This study investigated the interaction between TMP ...
Bibliographical & Catalog Notes
Published for the American College of Veterinary Pharmacology and Therapeutics, the Association for Veterinary Clinical Pharmacology and Therapeutics (UK), and the European Association for Veterinary Pharmacology and Toxicology.
Also issued online.
Vol. 3, no. 1 (1980)19920818 Notice not published Printed on acid-free paper